medigraphic.com
SPANISH

Alergia, Asma e Inmunología Pediátricas

Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 1

<< Back

Alerg Asma Inmunol Pediatr 2013; 22 (1)

Biopsia bronquial y lavado bronquioalveolar en el diagnóstico del asma persistente severa en niños

Huerta LJG, del Olmo TH, Ceballos CS
Full text How to cite this article

Language: Spanish
References: 20
Page: 19-28
PDF size: 189.17 Kb.


Key words:

Bronchial biopsy, bronchoalveolar lavag, einflammatory cells, T lymphocytes, glucocorticoids.

ABSTRACT

The prevalence of asthma worldwide is estimated at 300 million individuals. Latin America is a region that ranks among the highest incidence, with a percentages higher than 20% in children, mainly under four years old. There are many epidemiological factors in the development of this disease, including the lack of breastfeeding, early introduction of infant formula and dairy foods, passive smoking, early viral infections, environmental contaminants and early exposure to allergens as cockroach droppings and dust mites. In this context it is important to develop timely and accurate diagnoses based on pasymptoms to fi nd the best treatment for each case. Bronchial biopsies and bronchoalveolar lavage are straightforward procedures for obtaining samples that reveal the activation and increased infl ammatory cells and mediators in subjects with asthma, compared to subjects without the disease. Exacerbation of asthma is associated with an increase in the numbers and activation of eosinophils in the airway, as well as leukotrines, recipient T cells, killer T cells, prostaglandins, tryptase, soluble adhesion molecules, and lymphocytes. The use of inhaled glucocorticoids in the treatment of severe asthma has proven to be effi cient, but not in all cases, even some patients uncontrolled, with increased doses showed no improvement, in contrast exacerbating counterproductive effects of systemic steroids. It is important to deepen the studies to help us defi ne the symptoms of this entity in its higher severity levels, as well as improving treatments that although can not eradicate it, will help to alleviate the symptoms


REFERENCES

  1. Global Strategy for Asthma Management and Prevention (update). 2008: 2-13. http://www.ginasthma.org

  2. Cote J, Cartier A, Robichaud P et al. Influence on asthma morbidity of asthma education programs based on self management plans following treatment optimization. Am J Respir Crit Care Med 1997; 155(5): 1509-14.

  3. Horwood U, Fergusson DM, Shannon FT. Social and familial factors in the development of early childhood asthma. Pediatrics 1985; (5): 859-68.

  4. Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol 2005; 115(6): 1109-17.

  5. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002; 360(9342): 1313-22.

  6. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161(5): 1720-45.

  7. Larche M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol 2003; 111(3): 450-63.

  8. Miller AL, Lukacs NW. Chemokine receptors: understanding their role in asthmatic disease. Immunol Allergy Clin North Am 2004; 24(4): 667-83.

  9. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V et al. Airway remodeling in asthma. Chest 2003; 123(Suppl 3): 417S-22S.

  10. McParland BE, Macklem PT, Pare PD. Airway wall remodeling: friend or foe? J Appl Physiol 2003; 95(1): 426-34.

  11. Wang L, McParland BE, Pare PD. The functional consequences of structural changes in the airways: implications for airway hyperresponsiveness in asthma. Chest 2003; 123(Suppl 3): 356S-62S.

  12. Nizar N, Jarjour S, Ratko D, William C. Investigative use of bronchoscopy in asthma. Am J Respir Crit Care Med 1998; 157: 692-697.

  13. Vignola A, Bousquet J, Chanez A et al. Assessment of airway inflammation in asthma. Am J Respir Crit Care Med 1998; 157: 184S-187S.

  14. Asma infantil. Guías para su Diagnóstico y Tratamiento http://mx.search.yahoo.com/search/mx?p=ASMA&cop=mss& fl=l&vl=lang_es&xargs=&fr=fp-tab-web-t&b=21

  15. International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjuntivitis and atopic eczema: ISAAC. Lancet 1998; 351: 1228.

  16. Stewart J, Lor A. Pediatric asthma. Prim Care 2008; 35(1): 25-40.

  17. Sally E, Wenzel, Stanley JS et al. Bronchoscopic evaluation of severe asthma. Am J Respir Crit Care Med 1997; 156: 737-743.

  18. Jenkins A, Cool A, Szefler S et al. Histopathology of severe childhood asthma. Chest 2003; 124: 32-41.

  19. Lex C, Ferreira F, Zacharasiewicz et al. Airway eosinophilia in children with severe asthma, predictive values of noninvasive test. Am J Respir Crit Care Med 2006; 174: 1286-1291.

  20. Tillie-Leblond J, de Blic, Jaubert F et al. Airway remodeling is correlated with obstruction in children with severe asthma. Allergy 2008; 63: 533-541.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Alerg Asma Inmunol Pediatr. 2013;22